2月18日，微创医疗(00853)盘中上涨3.72%，截至14:23，报7.81元/股，成交3.0亿元。
微创医疗科学有限公司主要从事高端医疗器械的研发、生产和销售，业务包含心血管、脑血管神经调控、大血管生命支持与外周、电生理及心律管理、医疗机器人、妇科泌尿科消化科、关节脊柱创伤运动医学、眼科呼吸道、癌症治疗、内分泌诊断、再生医学、整容塑形等多个领域。该公司的产品已应用于全球100多个国家的两万家医院中，平均每5秒便有一个微创的产品用于挽救或延长生命、提升生命品质。
截至2024年中报，微创医疗营业总收入39.82亿元、净利润-6.9亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.